Medical information & sources
Updated 29 October 2026
How to read this page
Each line repeats a statement you can see in Forge, says what kind of statement it is (compound description, default value, arithmetic, or statistic), and links the source it is drawn from. Links open in Safari. Descriptions state a compound’s class and pharmacology as reported in the cited source. Where a description says “studied for”, that wording is deliberate: it describes research, not proven benefit, and much of it is preclinical.
Compound library — descriptions
- Semaglutide — Long-acting GLP-1 receptor agonist used for appetite suppression and glycemic control. Source: Alorfi & Algarni, Clin Pharmacol 2022; Knudsen & Lau, Front Endocrinol 2019
- Tirzepatide — Dual GIP/GLP-1 receptor agonist. Source: Nauck & D'Alessio, Cardiovasc Diabetol 2022
- Retatrutide — Triple GIP/GLP-1/glucagon receptor agonist (investigational). Source: Goldney et al., Curr Cardiovasc Risk Rep 2025
- Cagrilintide — Long-acting amylin analogue (investigational); studied in clinical trials alone and in fixed combination with semaglutide (CagriSema). Source: Dutta et al., Indian J Endocrinol Metab 2024
- AOD-9604 — Modified fragment of GH (Tyr-hGH 177-191) studied for fat metabolism. Source: Stier et al., J Endocrinol Metab 2013
- BPC-157 — Pentadecapeptide studied for tendon, ligament, and gut healing. Source: Seiwerth et al., Curr Pharm Des 2018
- TB-500 — Synthetic thymosin beta-4 fragment studied for cell migration and tissue repair. Source: Thymosin β4 review, Front Endocrinol 2021
- Pentadeca Arginate — L-arginine salt of BPC-157, patented for improved heat and gastric stability. No peer-reviewed studies of PDA itself. Source: US Patent 9,850,282 B2 (stable BPC-157 salts)
- GHK-Cu — Copper tripeptide studied for skin ageing and wound healing. Source: Pickart & Margolina, Int J Mol Sci 2018
- Ipamorelin — Selective GH secretagogue / ghrelin agonist with minimal cortisol impact. Source: Raun et al., Eur J Endocrinol 1998
- CJC-1295 (DAC) — Long-acting GHRH analogue, modified to bind serum albumin (estimated half-life 5.8–8.1 days). Source: Teichman et al., J Clin Endocrinol Metab 2006; Jetté et al., Endocrinology 2005
- CJC-1295 (no-DAC) — Synthetic GHRH analogue (Mod GRF 1-29) without the Drug Affinity Complex. Not characterised in controlled human studies. Source: Dominikowski et al., Front Endocrinol 2026
- Tesamorelin — GHRH analogue studied for visceral fat reduction. Source: Dhillon, Drugs 2011
- Sermorelin — GHRH analogue that stimulates endogenous GH release. Source: Prakash & Goa, BioDrugs 1999
- GHRP-2 — Growth hormone releasing peptide / ghrelin agonist. Source: Pralmorelin profile, Drugs R D 2004
- GHRP-6 — GH releasing peptide / ghrelin receptor agonist; increased appetite is a reported effect of this class. Source: Sigalos & Pastuszak, Sex Med Rev 2018
- Hexarelin — Potent GH secretagogue. Source: Massoud et al., Clin Endocrinol 1996
- MK-677 — Orally active ghrelin mimetic (GH secretagogue-receptor agonist) that raised GH and IGF-1 in a 2-year randomised trial in healthy older adults. Source: Nass et al., Ann Intern Med 2008
- Semax — Nootropic peptide studied for focus and neuroprotection. Source: Dergunova et al., Genes 2023; Tsai, Med Hypotheses 2007
- Selank — Anxiolytic nootropic peptide. Source: Medvedev et al., 2014
- Dihexa — Angiotensin IV analogue studied for synaptogenesis. Source: Wright et al., Prog Neurobiol 2015
- Cerebrolysin — Neuropeptide preparation studied for neuroprotection. Source: Jarosz et al., Brain Sci 2023
- Epithalon — Tetrapeptide studied for telomerase activation. Source: Araj et al., Int J Mol Sci 2025
- MOTS-c — Mitochondrial-derived peptide studied for metabolic regulation. Source: Wan et al., J Transl Med 2023
- SS-31 — Mitochondria-targeted peptide. Source: Sabbah et al., Biomed Pharmacother 2025
- NAD+ — Coenzyme central to cellular energy metabolism. Source: Cantó et al., Cell Metab 2015
- Humanin — Mitochondrial-derived peptide studied for cytoprotection. Source: Coradduzza et al., Biology 2023
- Thymosin Alpha-1 — Immunomodulating peptide. Source: Dominari et al., World J Virol 2020
- LL-37 — Naturally occurring antimicrobial peptide, active against bacteria, fungi and viruses, studied for its immunomodulatory effects. Source: Keshri et al., Int J Antimicrob Agents 2025
- Melanotan II — Non-selective melanocortin receptor agonist. Increases skin pigmentation; also reported to cause spontaneous erections and increased sexual desire. Not approved for any use. Source: Peters et al., CEN Case Rep 2020
- PT-141 — Melanocortin agonist studied for sexual arousal. Source: Edinoff et al., Neurol Int 2022
- Kisspeptin — Stimulates GnRH release; studied for reproductive hormones and libido. Source: Mills et al., Front Endocrinol 2022
- DSIP — Peptide studied for sleep regulation. Source: Graf & Kastin, Neurosci Biobehav Rev 1984
The “Also known as” row lists alternative names for a compound. Where it names a marketed product — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), tesamorelin (Egrifta) — the brand is the prescription product containing that compound. Sources: MedlinePlus, Semaglutide Injection; MedlinePlus, Tirzepatide Injection; MedlinePlus, Tesamorelin Injection
Dihexa: two earlier papers on this compound were retracted or carry an expression of concern and are not cited. Pentadeca Arginate: no peer-reviewed study of the compound itself exists; only the stability patent is cited.
Compound library — categories
Categories group compounds by how they are characterised in the literature. They are a filing system, not a statement that a compound produces the named effect.
- GLP-1 / Metabolic — Source: Moiz et al., eClinicalMedicine 2025
- Healing & Recovery — Source: Gwyer et al., Cell Tissue Res 2019
- GH Secretagogues — covers GH-releasing peptides and ibutamoren; CJC-1295 and ipamorelin are cited per compound above. Source: Sigalos & Pastuszak, Sex Med Rev 2018
- Cognitive — based on how Semax and Selank are characterised; the cited study measured brain connectivity, not cognitive performance. Source: Panikratova et al., Dokl Biol Sci 2020
- Longevity & Mitochondrial — Source: Kim et al., GeroScience 2020
- Immune — Sources: Dominari et al., World J Virol 2020; Dürr et al., Biochim Biophys Acta 2006
- Tanning & Libido — Source: Hadley, Peptides 2005
- Sleep — Source: Graf & Kastin, Neurosci Biobehav Rev 1984
Logging unit and routes
The “Logging unit” and “Logging routes” on each compound are the unit pre-selected and the options offered when you record a dose. They are app conveniences, not guidance, and have no medical source.
Vials, beyond-use dates and concentration
- 28-day beyond-use default — CDC injection-safety guidance, citing USP General Chapter <797>, says an opened or needle-punctured multi-dose vial should be dated and discarded within 28 days unless the manufacturer states another date, and never beyond its original expiry. That guidance is written for preserved multi-dose vials; the figure in Forge is an editable default, not a judgement about your vial. Source: CDC, Injection Safety: Clinical Safety
- Concentration = amount in the vial ÷ water added — the standard way a reconstituted product is expressed, for example 2 mg in 0.5 mL on an FDA label. The arithmetic ignores the volume of the powder itself, so the real concentration is slightly lower. Sources: DailyMed, EGRIFTA SV prescribing information; Wheeler et al., J R Soc Med 2004; Kumwenda et al., Pharmaceutical Journal 2024; WisTech Open, Nursing Dosage Calculations ch. 5.1
- Volume left and the diluent you enter (for example bacteriostatic water) are your own bookkeeping; no source is attributed to them.
Injection site rotation
- Rotating injection sites helps prevent lipohypertrophy, a common complication of repeated injection at the same spot. Forge shows the site you logged least recently to help you rotate. Source: Frid et al., Mayo Clin Proc 2016
- Moving to the next area each week is one published rotation pattern. Source: Barola et al., 2018
- The colour bands on the body map show how recently you logged each site. They are a tracking convention, not a clinical rest interval or a judgement of whether a site has healed.
Onboarding figures
- About half of people don’t stick with long-term treatment as prescribed — Sources: World Health Organization, 2003; Brown & Bussell, Mayo Clin Proc 2011
- People who track their behaviour consistently lose more weight than those who don’t — Source: Burke et al., J Am Diet Assoc 2011
- The weight-pace slider — the loss range offered (about 0.25–0.9 kg a week) overlaps the 1–2 lb (about 0.45–0.9 kg) a week the CDC describes as a gradual, steady rate; the slider’s lowest settings are slower than that. The gain range (0.1–0.4 kg a week) is an app assumption with no cited source. Source: CDC, Steps for Losing Weight
- The 30-day consistency curve is illustrative and not derived from data.
Nutrition defaults
- 2,200 kcal — a tabulated estimated calorie need in the Dietary Guidelines for Americans. It is a placeholder, not your requirement; needs vary with age, sex, height, weight and activity. Sources: Dietary Guidelines for Americans 2020–2025, Appendix 2; Merck Manual, estimated calorie needs table
- 140 g protein — within the 1.4–2.0 g/kg range the International Society of Sports Nutrition reports for active adults of 70–100 kg. Source: ISSN position stand on protein, 2017
- The carbohydrate / fat split sits inside the Acceptable Macronutrient Distribution Ranges for adults. Source: ODPHP, Acceptable Macronutrient Distribution Ranges
- For comparison, the FDA’s Daily Values on food labels are 275 g carbohydrate and 78 g fat on a 2,000-kcal reference diet; Forge’s 260 g and 75 g placeholders are in the same range, not derived from them. Sources: FDA, Daily Value on Nutrition and Supplement Facts labels; FDA, How to Understand and Use the Nutrition Facts Label
Hydration
- 64 oz (8 glasses) a day is a convention with no supporting evidence, kept only as a familiar starting value. Source: Valtin, Am J Physiol 2002
- Total water intake — the US National Academies give no glasses-per-day rule; they report about 2.7 L (91 oz) for women and 3.7 L (125 oz) for men from all drinks and food, and note most healthy people meet their needs by letting thirst guide them. Source: National Academies, Dietary Reference Intakes for Water (2004)
- A glass is 8 US fl oz, one cup, about 237 mL. Sources: NIST Handbook 44, Appendix C; NIST SP 811, Appendix B.9; 21 CFR 101.9(b)(5)(viii)
Activity and sleep displays
- 10,000 steps is widely promoted but not evidence-based; the cited meta-analysis found benefit plateauing at about 6,000–10,000 steps a day depending on age. It is a display scale, not a target Forge sets for you. Source: Paluch et al., Lancet Public Health 2022
- 500 kcal active energy is an app placeholder with no source.
- Sleep bars scale to 9 hours, the top of the 7–9 hour range the National Sleep Foundation reports for adults. Source: Hirshkowitz et al., Sleep Health 2015
Meal scan estimates
- Calories and macros from a photo are an AI model’s approximate reading, not a measurement. Published reviews of image-based calorie estimation report errors of up to roughly 38% against weighed food. Edit them freely and do not rely on them for medical or dietary decisions. No health score is displayed in this version. Source: Shonkoff et al., 2023
Legal note
- HIPAA applies to covered entities — health plans, clearinghouses and providers that transmit health information electronically — and their business associates. Forge is none of these, so the data you enter is not protected health information under HIPAA, and Forge does not claim HIPAA compliance. Source: 45 CFR § 160.102
Something missing?
If you find a figure in Forge that is not listed here, or a source that does not say what we say it says, email support@forgepeptide.app and we will fix it.